Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

This study has been completed.

Study NCT00802464 Information provided by GlaxoSmithKline

First Received: December 4, 2008 Last Updated: October 21, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: November 10, 2009